Skip to main content

Table 1 Bactericidal activity of hexylresorcinol lozenges

From: Bactericidal activity of hexylresorcinol lozenges against oropharyngeal organisms associated with acute sore throat

Challenge organismTest control count* (log10 cfu/mL ± SD)Contact time (min)
151030
Averagea log reduction (log10 cfu/mL ± SD)
Staphylococcus aureus6.7 ± 0.13.3 ± 0.25.7 ± 0.25.7 ± 0.25.7 ± 0.2
Streptococcus pyogenes6.6 ± 0.12.9 ± 0.24.3 ± 0.45.6 ± 0.15.6 ± 0.1
Moraxella catarrhalis7.2 ± 0.14.7 ± 0.46.2 ± 0.16.2 ± 0.16.2 ± 0.1
Haemophilus influenzae6.8 ± 0.45.8 ± 0.45.8 ± 0.45.8 ± 0.45.8 ± 0.4
Fusobacterium necrophorum5.5 ± 0.24.5 ± 0.24.5 ± 0.24.5 ± 0.24.5 ± 0.2
  1. Bactericidal activity, defined as a decrease in bacterial count (log10 cfu/mL)
  2. cfu colony-forming units, SD standard deviation
  3. *Average of the three test replicates